Personalized Evaluation of Susptected Myocardial Ischemia
Enrolling by invitationPhase 3NCT06708000
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to assess whether the use of clinical risk models, known as Clinical Likelihood (CL) models, can reduce the need for diagnostic examinations without negatively impacting quality of life or prognosis after 12 months in patients with stable new onset chest pain. Additionally, the project will evaluate a newly developed method called Laser Speckle Contrast Imaging for measuring function and oxygen content in the smallest blood vessels (microvasculature) of the hand, which may also reflect blood flow and oxygen content in the microvasculature of the heart.
Study details
- Official title
- Personalized Evaluation of Suspected Myocardial Ischemia
- Conditions
- Chronic Coronary Syndrome
- Angina Pectoris
- Coronary Artery Disease
- Myocardial Ischemia
- Arteriosclerosis
- Interventions
- Diagnostic test: Clinical Likelihood (CL) Model-Based Diagnostic Strategy
- Diagnostic test: Standard of care treatment
- Sponsor
- Gødstrup Hospital
- Start date
- 2024-11-20
- Primary completion
- 2027-12-31
- Sex
- All
- Age range
- from 30 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with de novo chest pain referred on suspicion of stable ischemic CAD * Patients capable of providing written informed consent Exclusion Criteria: * Age \<30 years or \>75 years * Known ischemic heart disease, including previous PCI (with or without stent) and bypass surgery * Unstable angina pectoris at initial consultation * Severe COPD or asthma * Severe valvular disease * Absolute or relative contraindications for Cardiac CT: * allergy to iomeron * pregnant women, including women who are potentially pregnant or lactating * reduced kidney function with an estimated glomerular filtration rate \<40 ml/min * LVEF \<45%
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06708000